Advantage Alpha Capital Partners’s Arcosa ACA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q3
– Sell
-5,518
Closed -$460K – 167
2024
Q2
$460K Sell
5,518
-600
-10% -$50K 0.1% 103
2024
Q1
$525K Sell
6,118
-562
-8% -$45.8K 0.1% 108
2023
Q4
$552K Buy
+6,680
New +$490K 0.1% 108
2023
Q2
– Sell
-11,776
Closed -$743K – 88
2023
Q1
$743K Sell
11,776
-2,429
-17% -$143K 0.15% 107
2022
Q4
$772K Buy
14,205
+1,520
+12% +$90.3K 0.16% 97
2022
Q3
$725K Sell
12,685
-981
-7% -$54.4K 0.13% 82
2022
Q2
$635K Sell
13,666
-9,830
-42% -$515K 0.11% 92
2022
Q1
$1.34M Buy
23,496
+13,896
+145% +$716K 0.2% 103
2021
Q4
$506K Buy
9,600
+1,400
+17% +$74.9K 0.07% 119
2021
Q3
$411K Buy
8,200
+1,826
+29% +$94.6K 0.07% 123
2021
Q2
$374K Buy
6,374
+254
+4% +$15.7K 0.07% 125
2021
Q1
$398K Buy
+6,120
New +$376K 0.08% 115

Other funds holding ACA

Advantage Alpha Capital Partners's ACA Position: Q3 2024 in Review

Advantage Alpha Capital Partners sold out of Arcosa (ACA) in Q3 2024, closing a stake of 5,518 shares — an estimated $460K sold.

Advantage Alpha Capital Partners first reported a position in ACA in Q1 2021 and held it in 12 quarters. The position peaked at $1.34M in Q1 2022. 324 funds tracked by Wall St. Rank hold ACA as of Q3 2024.

  • Advantage Alpha Capital Partners reported no remaining Arcosa position as of Q3 2024 after selling out during the quarter.
  • Advantage Alpha Capital Partners sold 5,518 Arcosa shares in Q3 2024, an estimated $460K.
  • Advantage Alpha Capital Partners first reported a position in Arcosa in Q1 2021 and held it in 12 quarters.
  • Advantage Alpha Capital Partners's Arcosa position peaked at $1.34M in Q1 2022.
  • 324 funds tracked by Wall St. Rank held Arcosa as of Q3 2024.

Based on Advantage Alpha Capital Partners's 13F filing for Q3 2024, filed 13 Nov 2024.